Document:

Termination and Release Agreement - Joan McCanless

 Exhibit 10.57 
 TERMINATION AND RELEASE AGREEMENT 
 This TERMINATION
AND RELEASE AGREEMENT (this “Agreement”), is made and entered into this 14th day of September, 2011, by and between MEDCATH CORPORATION, a Delaware corporation (“MedCath”), and JOAN McCANLESS (“Executive”). 

For good and valuable consideration, the sufficiency and receipt of which is hereby acknowledged, the parties do hereby agree, covenant
and stipulate as follows: 
 1. Termination of Employment Agreement. Executive has served as an officer of MedCath
pursuant to the terms and provisions of an Employment Agreement between MedCath and Executive dated as of September 30, 2005, as amended (the “Employment Agreement”). Effective as of the date of this Agreement, the Employment
Agreement is hereby terminated. Notwithstanding the termination of the Employment Agreement, Executive shall continue serving the Company as an at will employee until her employment is terminated by the Company or she resigns. 

2. Liquidation of Company’s Severance Obligations. In consideration of Executive’s entering into this Agreement and the
Executive’s release of MedCath as provided herein, MedCath agrees to (i) pay to Executive a lump sum payment of $633,888 on December 16, 2011 and (ii) complete, on or before September 15, 2012, all action necessary or
appropriate (including making a lump sum payment to Executive or pre-pay premiums to the extent necessary) to provide Executive fully paid major medical insurance coverage for the two year period following Executive’s separation from service.
From and after the date of this Agreement, Executive shall not be entitled to any cash severance payments or any other severance benefits under the Employment Agreement upon or following the termination of Executive’s employment with MedCath
for any reason. 
 3. Survival of Certain Provisions. The provisions of the Employment Agreement related to
non-competition, non-solicitation and non-disclosure of the Company’s confidential information and the enforcement of those provisions shall survive the termination of the Employment Agreement. The provisions of the Employment Agreement related
to compensation, employee benefits and expenses shall continue to apply to the Executive as an at will employee until her employment is terminated by the Company or she resigns. 

4. Release. Executive, for herself, her heirs, executors, administrators, and assigns, hereby covenants and agrees that she
irrevocably and unconditionally releases, acquits and forever discharges MedCath, its predecessors, successors, parent companies, affiliates, subsidiaries, and assigns, and their respective officers, directors, as well as each of MedCath’s
employees and agents (MedCath and MedCath’s officers, directors, employees, subsidiaries, successors, parent companies, affiliates, assigns, and agents being collectively referred to herein as the “Releasees”), or any of them,
from any and all charges, complaints, claims, liabilities, obligations, promises, demands, costs, losses, debts, and expenses (including attorneys’ fees and costs actually incurred), of any nature whatsoever, in law or equity, arising out of
the termination of the Employment Agreement. 
 5. Tax Withholding and Reporting. MedCath shall be entitled to withhold
from the benefits and payments described herein all income and employment taxes required to be withheld by applicable law. 
 6.
Governing Law and Venue. The interpretation and enforcement of this Agreement shall be governed by the internal laws and judicial decisions of the State of North Carolina, without regard to any principles of conflicts of laws. Executive, for
herself and her successors and assigns, hereby expressly and irrevocably (a) consents to the exclusive jurisdiction of the state or federal courts located in Charlotte, North Carolina for any action arising out of or related to this Agreement,
and (b) waives any and all objection to any such action based on venue or forum non conveniens. 

 7. Notices. Any notice or other communications to be given hereunder shall be deemed
to have been given or delivered when delivered by hand to the individuals named below or when deposited in the United States mail, registered or certified, with proper postage and registration or certification fees prepaid, addressed to the parties
as follows (or to such other address as one party shall give the other in the manner provided herein): 
 If to MedCath, to:

  

											
		 		 	 MedCath Corporation

10720 Sikes Place, Suite 300
 Charlotte, North
Carolina 28277
  
 Attn: Chief Executive Officer
	 		 	

 with a copy to: 
  

											
		 		 	 Hal A. Levinson, Esq.
 Moore & Van Allen, PLLC
 100 N. Tryon Street, Floor 47

Charlotte, North Carolina 28208-4003
	 		 	

 If to Executive, to the most recent address on MedCath’s employment records for Executive.

 8. Whole Agreement, Amendment and Severability. This document contains the whole and entire understanding and
agreement between the parties hereto, superseding any and all prior and contemporaneous agreements, representations, promises, inducements and understandings of the parties, including without limitation the Employment Agreement except as otherwise
stated herein. There are no other understandings, promises, covenants or agreements between the parties regarding the subject matter of this Agreement, except as specifically set forth herein. This Agreement may not be amended, modified or altered
in any fashion except in writing executed by the parties hereto with the same formality as with which this Agreement is executed. Executive understands and agrees that each clause of this Agreement is a separate and independent clause, and that, if
any clause should be found unenforceable, such clause should be and is hereby severed from this Agreement and will not affect the enforceability of any of the other clauses herein. Nothing in this Agreement shall be construed to modify, replace or
terminate the Indemnification Agreement entered into between MedCath and the Executive dated January 25, 2011. 
 9.
Assignability. Neither this Agreement, nor any right or interest hereunder, shall be assignable by Executive, Executive’s beneficiaries, or legal representatives. MedCath shall retain the right to assign this Agreement. 

IN WITNESS WHEREOF, MedCath has caused this Agreement to be executed by a duly authorized officer, and Executive has hereunto set
her hand and seal, all as of the day and year first above written. 
  

					
	/s/ Joan McCanless	 	[SEAL]
	Joan McCanless	 	
		 	
		 	
	MEDCATH CORPORATION	 	
			
	By:	 	/s/ James A. Parker	 	
	Name:	 	James A. Parker	 	
	Title:	 	Chief Executive OfficerEmployment Agreement

 Exhibit 10.58 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this
“Agreement”) is made and entered into as of September 14, 2011, but effective as of September 23, 2011 (the “Effective Date”) by and between MEDCATH CORPORATION, a Delaware corporation (the
“Company”), and LORA RAMSEY (the “Employee”). 
 RECITALS 

The Company desires to continue to employee the Employee and the Employee desires to continue her employment with the Company in
accordance with the terms of this Agreement. 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto agree as follows: 
 1. Employment. Subject to the terms and
conditions of this Agreement, the Company agrees to continue to employ the Employee during the term hereof as Vice President, Chief Financial Officer and Secretary. The Employee hereby accepts continued employment with the Company and agrees to
devote her full working time and efforts, to the best of her ability, experience and talent, to the performance of services, duties and responsibilities in connection therewith. 

2. Term of Employment. The Employee’s term of employment under this Agreement shall commence on the
Effective Date and, subject to the terms hereof, shall terminate on the third (3rd) anniversary of the Effective Date. 
 3. Compensation. 

(a) Base Salary. The Company shall pay Employee base salary (“Base Salary”) at an initial rate of $260,000 per
annum commencing as of the Effective Date. The Employee’s Base Salary shall be increased to $267,800 per annum effective as of October 1, 2012, and to $275,834 per annum effective as of October 1, 2013. The Employee’s Base Salary
shall be payable in accordance with the normal payroll practices of the Company but no less frequently than monthly. 
 (b)
Signing Bonus; Vesting of Unvested Restricted Stock Awards. The Company shall pay the Employee a signing bonus in the amount of $283,500 in a single cash payment within 10 business days after the Effective Date. Upon September 30, 2011,
all 

 
unvested shares of restricted stock awarded to the Employee under the Company’s equity incentive plans shall become fully vested and nonforfeitable; provided, however, such
shares shall not be transferable by the Employee until the occurrence of a “Change in Control” of the Company. For purposes of this Agreement, the term “Change in Control” shall have the meaning given such term under the
Company’s equity incentive plans. 
 (c) 401(k) Bonus. The Company shall pay the Employee an annual bonus to offset
the matching contribution benefit the Employee will lose upon the Company’s termination of its defined contribution retirement plan (the “401(k) Bonus”). The 401(k) Bonus will be grossed up for all applicable income and
employment taxes and will be paid in a single cash payment within 10 business days after September 30, 2012, September 30, 2013 and September 30, 2014 (each, a “401(k) Bonus Payment Date”). The amount of the
401(k) Bonus payable as of each 401(k) Bonus Payment Date (prior to being grossed up for applicable taxes) is set forth in the following table: 
  

					
	 Bonus Year
	  	401(k) Bonus	 
	 September 30, 2012
	  	$	6,240.00	  
	 September 30, 2013
	  	$	6,427.20	  
	 September 30, 2014
	  	$	6,620.02	  

 In the event the Employee’s employment with the Company terminates prior to a 401(k) Bonus Payment Date for any
reason other than an involuntary termination by the Company without Cause pursuant to Section 6(a), (i) the 401(k) Bonus otherwise payable as of such 401(k) Bonus Payment Date shall be prorated to reflect the portion of the year
preceding such 401(k) Bonus Payment Date during which the Employee was employed and paid within 10 business days after the Employee’s termination of employment and (ii) the Employee shall forfeit any and all rights to any future 401(k)
Bonuses. 
 4. Expenses. The Employee is authorized to incur reasonable expenses in carrying out her duties and
responsibilities under this Agreement, including, without limitation, expenses for travel and similar items related to such duties and responsibilities. The Company will reimburse Employee for all such expenses upon presentation by Employee from
time to time of 

  
 2 

 
appropriately itemized and approved (consistent with the Company’s policy) accounts of such expenditures. 
 5. Vacation. The Employee shall be entitled to five (5) weeks of paid vacation during the 12 month period commencing with the Effective Date and on each anniversary thereof during the term of
this Agreement, as well as all recognized federal holidays. 
 6. Termination of Employment. 

(a) Termination by the Company without Cause. The Company shall have the right to terminate the employment of
the Employee under this Agreement at any time without Cause by providing the Employee 30 days advance written notice of such termination. In the event the Employee’s employment is terminated by the Company without Cause, the Employee shall be
entitled to receive (i) her accrued but unpaid Base Salary and (ii) Base Salary and 401(k) Bonuses through the third (3rd) anniversary of the Effective Date. As used in this Agreement, the term “Cause” shall mean and
be limited to (i) willful misconduct by Employee which results in a demonstrable injury (which is other than de minimis or insignificant) to the Company, (ii) willful and continued failure by Employee to perform her material duties with
respect to the Company or its subsidiaries, which failure continues beyond 5 days after a written demand for substantial performance of such duties was given to Employee by the Company, or (iii) Employee’s conviction of, or plea of nolo
contendere to, a felony or to a misdemeanor involving moral turpitude. 
 (b) Termination by the Company for Cause or
Resignation by Employee. The Company shall have the right to immediately terminate the employment of the Employee under this Agreement for Cause and the Employee shall have the right to resign from employment hereunder at any time. In the event
that Employee’s employment is terminated by the Company for Cause or the Employee resigns from employment hereunder, the Employee shall be entitled to receive only accrued but unpaid Base Salary for past unpaid work performed and the prorated
401(k) Bonus described in Section 3(c) and no further compensation or benefits hereunder. 
 (c) Permanent
Disability. If Employee becomes totally and permanently Disabled (as defined below) the Company or Employee may terminate Employee’s employment under this Agreement upon 30 days prior written notice, and the Employee shall be entitled to
receive accrued but unpaid Base Salary and the prorated 401(k) Bonus described in Section 3(c). For purposes of this Agreement, “Disabled” shall mean that due to physical or mental illness or

  
 3 

 
injury, the Employee is unable to perform the essential functions of her position for either: (i) ten (10) consecutive weeks or longer; or (ii) a total of twelve (12) weeks or
longer in any twelve (12) month period. The determination of Disability shall be made by the Board of Directors of the Company. 
 (d) Death. In the event of the Employee’s death during the term of her employment hereunder, the Employee’s estate or designated beneficiaries shall receive the Employee’s accrued
but unpaid Base Salary and the prorated 401(k) Bonus described in Section 3(c). 
 7. Compliance with Code
Section 409A. (a) Notwithstanding anything in this Agreement to the contrary, if any amount or benefit that the Company determines would constitute non-exempt “deferred compensation” for purposes of Section 409A of the
Internal Revenue Code of 1986 (the “Code”) would otherwise be payable or distributable under this Agreement by reason of Employee’s Separation from Service, then to the extent necessary to comply with Code Section 409A:

 (i) if the payment or distribution is payable in a lump sum, Employee’s right to receive payment or
distribution of such non-exempt deferred compensation will be delayed until the earlier of Employee’s death or the first day of the seventh month following the Employee’s Separation from Service; and 

(ii) if the payment or distribution is payable over time, the amount of such non-exempt deferred compensation that would
otherwise be payable during the six (6) month period immediately following Employee’s Separation from Service will be accumulated and Employee’s right to receive payment or distribution of such accumulated amount will be delayed until
the earlier of Employee’s death or the first day of the seventh month following Employee’s Separation from Service and paid on the earlier of such dates, without interest, and the normal payment or distribution schedule for any remaining
payments or distributions will commence. 
 (b) To the extent any expense reimbursement or in-kind benefit to which Employee is
or may be entitled to receive under this Agreement constitutes non-exempt “deferred compensation” for purposes of Section 409A of the Code, then (i) such reimbursement shall be paid to Employee as soon as administratively
practicable after Employee submits a valid claim for reimbursement, but in no event later than the last day of Employee’s taxable year following the taxable year in which the expense was incurred, (ii) the amount of expenses eligible for
reimbursement, or in-kind benefits provided, during any taxable year of Employee shall not affect the expenses eligible for reimbursement, or in- kind benefits to be provided, in 

  
 4 

 
any other taxable year of Employee, and (iii) Employee’s right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit. 

(c) As used herein, the term “Separation from Service” shall mean the termination of Employee’s employment with the
Company (or its subsidiaries), provided such termination also constitutes a separation of service under Section 409A of the Code. 
 8. Notices. All notices or communications hereunder shall be in writing, addressed as follows: 
 To the Company: 
 MedCath Corporation 

10720 Sikes Place, Suite 300 
 Charlotte, North Carolina 28277 
 Attn: Board of Directors 

with a copy (which shall not constitute notice) to: 
 Moore & Van Allen, PLLC 
 100 N. Tryon Street, Suite 4700 

Charlotte, North Carolina 28202-4003 
 Attn: Hal A. Levinson, Esq. 
 To the Employee: 

The most recent address 
 on the Company’s employment 
 records for the Employee 

Any such notice or communication shall be delivered by hand, by telecopy (with machine confirmation) or by courier or sent certified or registered mail,
return receipt requested, postage prepaid, addressed as above (or to such other address as such party may designate in a notice duly delivered as described above), and the third business day after the actual date of mailing shall constitute the time
at which notice was given. 
 9. Severability. If any provision of this Agreement shall be declared to be invalid or
unenforceable, in whole or in part, such invalidity or unenforceability shall not affect the remaining provisions hereof which shall remain in full force and effect. 
 10. Assignment. This Agreement shall be binding upon and inure to the benefit of the heirs and representatives of Employee and the assigns and successors of the Company, but neither this Agreement
nor any rights or obligations hereunder shall be assignable or otherwise subject to hypothecation by Employee (except by will or by operation of the laws of intestate succession) or by the Company, except that the Company may assign this Agreement
to any 

  
 5 

 
successor (whether by merger, purchase or otherwise) to all or substantially all of the stock, assets or businesses of the Company, if such successor expressly agrees to assume the obligations of
the Company hereunder. 
 11. Amendment. This Agreement may only be amended by written agreement of the parties hereto.

 12. Survivorship. The respective rights and obligations of the parties hereunder shall survive any termination of this
Agreement to the extent necessary to the intended preservation of such rights and obligations, including the provisions of Section 9 herein. 
 13. Governing Law. This Agreement shall be construed, interpreted and governed in accordance with the laws of the State of North Carolina without reference to rules relating to conflicts of law.

 14. Withholding. The Company shall be entitled to withhold from payment any amount of withholding required by law.

 15. Effect on Existing Agreements. This Agreement contains the entire understanding between the parties hereto with
respect to the Employee’s employment by the Company and supersedes in all respects any currently existing employment agreements. 
 16. Counterparts. This Agreement may be executed in two or more counterparts, each of which will be deemed an original. 

  
 6 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by a duly
authorized officer and the Employee has hereunto set her hand and seal, all as of the day and year first above written. 
  

			
	MEDCATH CORPORATION
		
	By:	 	/s/ James A. Parker
	Name:	 	 James A. Parker

	Title:	 	 Chief Financial Officer

	
	/s/ Lora Ramsey
		 	Lora Ramsey

  
 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]